Gabapentin Tablet
Product Images NDC 69097-812

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 69097-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 01

Table titled 'Gabapentin Dosage Based on Renal Function' detailing total daily dose range and dose regimen in mg for different creatinine clearance levels and post-hemodialysis supplemental doses. It outlines dosage adjustments based on renal function and provides supplemental dosing for patients on hemodialysis along with relevant footnotes explaining dose modifications.*

FDA Label Image

Gabapentin 02

A text panel showing a medical formula for calculating creatinine clearance (CLCr) with variables including age, weight, serum creatinine, and a gender adjustment factor for female patients.*

FDA Label Image

Gabapentin 03

A data table titled 'TABLE 2 Risk by Indication for Antiepileptic Drugs in the Pooled Analysis' showing comparative risk statistics for placebo and drug patients with events per 1000 patients across indications: Epilepsy, Psychiatric, Other, and Total. The table includes columns for placebo and drug event rates, relative risk, and risk difference.*

FDA Label Image

Gabapentin 04

Chemical structure of the active ingredient Gabapentin, showing a cyclohexane ring attached to an amino group (CH2NH2) and an acetic acid group (CH2CO2H).*

FDA Label Image

Gabapentin 05

A line graph showing mean pain scores over 8 weeks comparing placebo with Gabapentin 3600 mg/day. The x-axis represents weeks from baseline through an 8-week period divided into 4-week dose titration and 4-week fixed dose phases. The y-axis displays mean pain scores decreasing more steeply for Gabapentin than placebo.*

FDA Label Image

Gabapentin 06

A line graph showing mean pain scores over seven weeks comparing Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks including a 3-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain score values ranging from 0 to 10. Data shows decreasing pain scores for both Gabapentin doses compared to Placebo over time.*

FDA Label Image

Gabapentin 07

A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing two studies comparing placebo (PBO) and Gabapentin (GBP) at different doses. Study 1 compares PBO and GBP 3600 mg, and Study 2 compares PBO, GBP 1800 mg, and GBP 2400 mg. Percentages of responders are displayed above each bar, highlighting significantly higher response rates for Gabapentin groups compared to placebo.*

FDA Label Image

Gabapentin 08

A scatter plot comparing difference percentages across daily doses (600 mg, 900 mg, 1200 mg, 1800 mg) of a drug from three studies labeled as Study a, Study b, and Study c. The y-axis represents difference (%) and the x-axis represents daily dose (mg). Data points are differentiated by black, gray, and white squares for each study.*

FDA Label Image

Gabapentin 09

Label for Gabapentin Tablets USP 600 mg by Cipla USA Inc. The label specifies the product contains 100 tablets, with instructions for pharmacists to dispense the Medication Guide separately. It includes storage directions, a note to see the package insert for dosage and use, and manufacturing details listing InvaGen Pharmaceuticals and Cipla USA locations. A QR code and barcode are also present.*

FDA Label Image

Gabapentin 10

Gabapentin Tablets, USP 600 mg oral tablets label showing 100 tablets per container. The label includes storage instructions, manufacturer Ascent Pharmaceuticals, Inc., and labeler Cipla USA Inc. Barcode and lot/expiration number space are visible. The medication is for prescription use only.*

FDA Label Image

Gabapentin 11

Gabapentin Tablets, USP 800 mg oral tablets label by Cipla USA Inc. The label states the strength as 800 mg and the package size as 100 tablets. It includes storage instructions, dispensing information, manufacturer details (InvaGen Pharmaceuticals, a Cipla Ltd. subsidiary), and barcode with lot and expiration placeholders. The label is marked Rx only.*

FDA Label Image

Gabapentin 12

Gabapentin Tablets USP 800 mg oral tablet label from Cipla USA Inc., containing 100 tablets. The label includes storage instructions at controlled room temperature and dispensing requirements with a child-resistant closure. Manufactured by Ascent Pharmaceuticals, Inc., Central Islip, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.